D
M. Yu et al.
Special Topic
Synthesis
1H NMR (400 MHz, CDCl3): δ = 2.21 (s, 3 H), 2.64 (t, J = 6.7 Hz, 2 H),
4.21 (t, J = 6.7 Hz, 2 H), 6.71 (s, 1 H), 7.10 (d, J = 8.8 Hz, 2 H), 7.25 (d, J =
8.8 Hz, 2 H), 8.05 (s, 1 H).
1H NMR (300 MHz, CDCl3): δ = 2.21 (s, 3 H), 2.30 (s, 3 H), 2.62 (t, J =
6.0 Hz, 2 H), 4.19 (t, J = 6.0 Hz, 2 H), 6.53 (s, 1 H), 7.06–7.09 (m, 4 H),
8.05 (s, 1 H).
13C NMR (100 MHz, CDCl3): δ = 10.4, 21.4, 63.1, 92.9, 118.2, 127.2,
13C NMR (100 MHz, CDCl3): δ = 10.4, 20.6, 21.4, 63.2, 91.6, 117.5,
129.4, 138.5, 160.5, 160.9, 162.4.
129.9, 132.0, 137.1, 160.5, 160.9, 163.1.
Anal. Calcd for C13H13ClN2O3: C, 55.62; H, 4.67; N, 9.98. Found: C,
55.78; H, 4.70; N, 9.90.
Anal. Calcd for C14H16N2O3: C, 64.60; H, 6.20; N, 10.76. Found: C,
64.43; H, 6.25; N, 10.85.
Colorless crystal; M = 280.06; monoclinic; P21/n; a = 5.5307(8) Å, b =
21.530(3) Å, c = 11.1271(15) Å, α = 90.00°, β = 96.547(2)°, γ = 90.00°;
V = 1316.3(3) Å3; Z = 17; T = 273(2) K; F000 = 663, R1 = 0.0996, wR2 =
0.2753. CCDC 1011915 contains the supplementary crystallographic
data for 2a. The data can be obtained free of charge from The Cam-
structures.
2-{3-Methyl-5-[o-tolylamino]isoxazol-4-yl}ethyl Formate (2f)
Yield: 190 mg (73%); colorless semisolid.
1H NMR (300 MHz, CDCl3): δ = 2.14 (s, 3 H), 2.22 (s, 3 H), 2.53 (t, J =
6.6 Hz, 2 H), 4.10 (t, J = 6.6 Hz, 2 H), 6.25 (s, 1 H), 6.89 (t, J = 7.5 Hz,
1 H), 7.07–7.11 (m, 2 H), 7.20 (d, J = 9.0 Hz, 1 H), 7.95 (s, 1 H).
13C NMR (100 MHz, CDCl3): δ = 10.4, 17.5, 21.3, 63.2, 92.9, 118.1,
122.8, 126.4, 126.9, 130.6, 138.0, 160.5, 160.7, 163.0.
2-{5-[(3-Chlorophenyl)amino]-3-methylisoxazol-4-yl}ethyl For-
mate (2b)
Anal. Calcd for C14H16N2O3: C, 64.60; H, 6.20; N, 10.76. Found: C,
64.76; H, 6.14; N, 10.68.
Yield: 191 mg (68%); colorless semisolid.
1H NMR (400 MHz, CDCl3): δ = 2.19 (s, 3 H), 2.64 (t, J = 6.8 Hz, 2 H),
4.17 (t, J = 6.8 Hz, 2 H), 6.91 (dd, J = 8.0, 1.0 Hz, 1 H), 7.02–7.03 (m,
1 H), 7.13–7.17 (m, 2 H), 7.29 (s, 1 H), 8.01 (s, 1 H).
2-{3-Methyl-5-[phenylamino]isoxazol-4-yl}ethyl Formate (2g)
Yield: 185 mg (75%); white solid; mp 84–85 °C.
IR (KBr): 3217, 3116, 3051, 3004, 2962, 2933, 1712, 1650, 1591, 1529,
13C NMR (100 MHz, CDCl3): δ = 10.3, 21.1, 62.9, 93.5, 114.8, 116.6,
121.8, 130.2, 134.8, 141.2, 160.7, 160.9, 162.1.
1490, 1427, 1319, 1178, 1166, 1110, 973, 754, 688 cm–1
.
1H NMR (400 MHz, CDCl3): δ = 2.21 (s, 3 H), 2.64 (t, J = 6.7 Hz, 2 H),
4.20 (t, J = 6.7 Hz, 2 H), 6.67 (s, 1 H), 7.00 (t, J = 7.2 Hz, 1 H), 7.17 (d, J =
7.8 Hz, 2 H), 7.26–7.31 (m, 2 H), 8.05 (s, 1 H).
Anal. Calcd for C13H13ClN2O3: C, 55.62; H, 4.67; N, 9.98. Found: C,
55.78; H, 4.61; N, 9.89.
13C NMR (100 MHz, CDCl3): δ = 10.4, 21.3, 63.0, 92.4, 117.0, 122.1,
129.3, 139.8, 160.6, 160.8, 162.7.
2-{5-[(2-Chlorophenyl)amino]-3-methylisoxazol-4-yl}ethyl For-
mate (2c)
Anal. Calcd for C13H14N2O3: C, 63.40; H, 5.73; N, 11.38. Found: C,
63.23; H, 5.77; N, 11.44.
Yield: 196 mg (70%); white solid; mp 77–78 °C.
IR (KBr): 3375, 3153, 3033, 2972, 2960, 1726, 1643, 1593, 1523, 1469,
1458, 1425, 1309, 1176, 1035, 810, 756, 518 cm–1
.
1H NMR (400 MHz, CDCl3): δ = 2.22 (s, 3 H), 2.66 (t, J = 6.0 Hz, 2 H),
4.24 (t, J = 6.0 Hz, 2 H), 6.90 (t, J = 7.6 Hz, 1 H), 7.12 (s, 1 H), 7.20 (t, J =
7.6 Hz, 1 H), 7.34 (d, J = 8.0 Hz, 1 H), 7.50 (d, J = 8.0 Hz, 1 H), 8.06 (s,
1 H).
Acknowledgment
Financial support of this research by the National Natural Science
Foundation of China (21172211 and 21542006) is greatly acknowl-
edged.
13C NMR (100 MHz, CDCl3): δ = 10.4, 21.3, 63.6, 95.2, 116.7, 120.7,
122.2, 128.0, 129.3, 136.6, 160.3, 160.5, 161.8.
Anal. Calcd for C13H13ClN2O3: C, 55.62; H, 4.67; N, 9.98. Found: C,
55.44; H, 4.72; N, 10.06.
Supporting Information
Supporting information for this article is available online at
2-{3-Methyl-5-[p-tolylamino]isoxazol-4-yl}ethyl Formate (2d)
S
u
p
p
ortiInfogrmoaitn
S
u
p
p
o
nrtogI
f
rmoaitn
Yield: 217 mg (79%); colorless semisolid.
1H NMR (400 MHz, CDCl3): δ = 2.18 (s, 3 H), 2.24 (s, 3 H), 2.28 (s, 3 H),
2.55 (t, J = 6.5 Hz, 2 H), 4.13 (t, J = 6.5 Hz, 2 H), 6.26 (s, 1 H), 6.96 (d, J =
8.0 Hz, 1 H), 6.99 (s, 1 H), 7.14 (d, J = 8.0 Hz, 1 H), 8.00 (s, 1 H).
13C NMR (100 MHz, CDCl3): δ = 10.4, 17.5, 20.6, 21.3, 63.2, 91.6, 119.3,
127.4, 131.4, 132.9, 135.1, 160.6, 160.8, 163.5.
References
(1) Loh, B.; Vozzolo, L.; Mok, B. J.; Lee, C. C.; Fitzmaurice, R. J.;
Caddick, S.; Fassati, A. Chem. Biol. Drug Des. 2010, 75, 461.
(2) (a) Kumbhare, R. M.; Kosurkar, U. B.; Ramaiah, M. J.; Dadmal, T.
L.; Pushpavalli, S. N. C. V. L.; Pal-Bhadra, M. Bioorg. Med. Chem.
Lett. 2012, 22, 5424. (b) Changtam, C.; Hongmanee, P.;
Suksamrarn, A. Eur. J. Med. Chem. 2010, 45, 4446.
(c) Maksimovic-Ivanic, D.; Mijatovic, S.; Harhaji, L.; Miljkovic,
D.; Dabideen, D.; Cheng, K. F.; Mangano, K.; Malaponte, G.; Al-
Abed, Y.; Libra, M.; Garotta, G.; Nicoletti, F.; Stosic-Grujicic, S.
Mol. Cancer Ther. 2008, 7, 510.
Anal. Calcd for C15H18N2O3: C, 65.68; H, 6.61; N, 10.21. Found: C,
65.90; H, 6.56; N, 10.14.
2-{5-[(2,4-Dimethylphenyl]amino)-3-methylisoxazol-4-yl}ethyl
formate (2e)
Yield: 198 mg (76%); white solid; mp 138–139 °C.
IR (KBr): 3191, 3105, 3089, 2989, 2962, 1716, 1643, 1612, 1587, 1521,
1487, 1456, 1402, 1234, 1180, 1168, 958, 694, 501 cm–1
.
© Georg Thieme Verlag Stuttgart · New York — Synthesis 2016, 48, A–E